Search research articles
Contact Us
Filters
Showing results (31-40 of 76) with videos related to
Page
of 8
Sort By:
Tomography (Ann Arbor, Mich.)
|
April 30, 2021
Whole-Body [<sup>18</sup>F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687
Mark Muzi, Finbarr O'Sullivan, Timothy G Perk, et al.
The Journal of Urology
|
September 5, 2018
The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial
Gerald L Andriole, Lale Kostakoglu, Albert Chau, et al.
Genes, Chromosomes & Cancer
|
March 27, 2012
Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the Children's Oncology Group
Fenghai Duan, Lynette M Smith, Donna M Gustafson, et al.
Cancer
|
July 29, 2014
Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial
Ilana F Gareen, Fenghai Duan, Erin M Greco, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 27, 2012
Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts
Bruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 30, 2017
Hospice Admission and Survival After <sup>18</sup>F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
Ilana F Gareen, Bruce E Hillner, Lucy Hanna, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 21, 2016
Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235
Jose G Bazan, Fenghai Duan, Bradley S Snyder, et al.
Plos One
|
October 3, 2018
Correction: Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial
Tobias Peikert, Fenghai Duan, Srinivasan Rajagopalan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 17, 2009
PET and PET/CT reports: observations from the National Oncologic PET Registry
R Edward Coleman, Bruce E Hillner, Anthony F Shields, et al.
Cancer
|
January 3, 2013
Examining whether lung screening changes risk perceptions: National Lung Screening Trial participants at 1-year follow-up
Elyse R Park, Ilana F Gareen, Amanda Jain, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 76) with videos related to
Sort By:
Page
of 8
Tomography (Ann Arbor, Mich.)
|
April 30, 2021
Whole-Body [<sup>18</sup>F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687
Mark Muzi, Finbarr O'Sullivan, Timothy G Perk, et al.
The Journal of Urology
|
September 5, 2018
The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial
Gerald L Andriole, Lale Kostakoglu, Albert Chau, et al.
Genes, Chromosomes & Cancer
|
March 27, 2012
Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the Children's Oncology Group
Fenghai Duan, Lynette M Smith, Donna M Gustafson, et al.
Cancer
|
July 29, 2014
Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial
Ilana F Gareen, Fenghai Duan, Erin M Greco, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 27, 2012
Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts
Bruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 30, 2017
Hospice Admission and Survival After <sup>18</sup>F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
Ilana F Gareen, Bruce E Hillner, Lucy Hanna, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 21, 2016
Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235
Jose G Bazan, Fenghai Duan, Bradley S Snyder, et al.
Plos One
|
October 3, 2018
Correction: Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial
Tobias Peikert, Fenghai Duan, Srinivasan Rajagopalan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 17, 2009
PET and PET/CT reports: observations from the National Oncologic PET Registry
R Edward Coleman, Bruce E Hillner, Anthony F Shields, et al.
Cancer
|
January 3, 2013
Examining whether lung screening changes risk perceptions: National Lung Screening Trial participants at 1-year follow-up
Elyse R Park, Ilana F Gareen, Amanda Jain, et al.
Page
of 8